Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001415889-25-008367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-18 | 2025-03-15 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | +13.5K | 29.8K | +83% | $0 |
| DM | 2025-03-18 | 2025-03-15 | STOK | Allan Jonathan | GC, CORP SEC | M - OptEx | $0.00 | -13.5K | 18.0K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-15 | M | A | 6,000 | $0.00 | 35,776 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-15 | M | A | 7,475 | $0.00 | 29,776 | D | — | — | (F1) The reported total includes an aggregate 825 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). |
| 3 | Derivative | Restricted Stock Units | 2025-03-15 | M | D | 7,475 | $0.00 | 14,950 | D | — · — to 2027-03-15 | 7,475 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F3) The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date. |
| 4 | Derivative | Restricted Stock Units | 2025-03-15 | M | D | 6,000 | $0.00 | 18,000 | D | — · — to 2028-03-15 | 6,000 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F4) The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date. |